Overview
Gram-negative infections present significant challenges in diagnosis and clinical management, making timely identification and appropriate antibiotic therapy important considerations in critical care settings.
Understanding healthcare professionals’ perceptions, diagnostic preferences, and treatment practices can help identify evolving clinical trends and areas for improvement.
A two-phase survey initiative, conducted from April to June 2024 and October to November 2024, aimed to gather insights into antibiotic therapy preferences among intensivists across India. The survey focused on understanding their perspectives on rapid diagnostic tests, early antibiotic treatment, and the management of multidrug-resistant (MDR) Gram-negative infections.
Campaign Approach
The campaign adopted a targeted digital outreach strategy to encourage intensivists to participate in the survey and share their clinical perspectives.
The key elements of the approach included:
- Specialty-Based Targeting: Reaching intensivists registered on the digital healthcare platform across India.
- Weekly SMS Communication: Promoting the survey through regular SMS campaigns to maintain visibility and encourage participation.
- Digital Touchpoints: Leveraging the mobile application and website to optimize outreach and direct healthcare professionals toward the survey.
- Two-Phase Engagement: Conducting the survey in two separate phases to capture responses and understand changes in clinical perceptions over time.
The objective was to generate more than 300 responses while gathering meaningful insights into antibiotic therapy preferences and rapid diagnostic practices.
Methodology
The survey targeted 9,122 intensivists across India through a structured digital engagement strategy.
SMS marketing was implemented as the primary outreach approach, supported by the mobile application and website. The campaign was conducted in two phases:
- Phase 1: April–June 2024
- Phase 2: October–November 2024
A total of 314 responses were received in Phase 1, followed by 311 responses in Phase 2.
The survey evaluated healthcare professionals’ perceptions of rapid diagnostic tests and antibiotic therapy practices for Gram-negative infections.
Key areas explored included:
- Preferences for rapid diagnostic tools in ICU blood culture-positive cases.
- Adoption of rapid diagnostics for early infection detection.
- Early use of CAZ-AVI in patients with MDR Gram-negative infections.
- Treatment preferences involving polymyxin-based therapies.
- Changes in clinical practices and antibiotic treatment decisions.
Campaign performance was assessed through reach, impressions, and survey responses, while the survey findings helped compare clinical perceptions and practices across both phases.
Result
The campaign successfully generated participation across both phases and provided valuable insights into antibiotic therapy practices among intensivists.
Overall campaign performance:
- Target Audience: 9,122 intensivists
- Phase 1 Impressions: 46,716
- Phase 1 Responses: 314
- Phase 2 Impressions: 48,933
- Phase 2 Responses: 311
- Total Responses Across Both Phases: 625
Key Survey Findings:
- Preference for Rapid Diagnostics: In Phase 1, 51.9% of respondents agreed and 30.3% strongly agreed with preferring rapid diagnostic options such as Xpert CarbaR/BioFire for ICU blood culture-positive cases. In Phase 2, the figures were 55.3% and 28.9%, respectively.
- Use of Rapid Diagnostics: The proportion of respondents using rapid diagnostics for 30–50% of ICU patients increased from 52.5% in Phase 1 to 55.9% in Phase 2.
- Early CAZ-AVI Treatment: In Phase 1, 42.7% of doctors reported using CAZ-AVI early in the patient journey based on rapid diagnostics, while 41.4% agreed it was used within 24 hours for MDR Gram-negative infections. In Phase 2, reported use within 24 hours increased to 61.1%.
- Polymyxin-Based Therapies: The proportion of ICU patients receiving polymyxin-based therapies in the 10–30% range decreased slightly in Phase 2, indicating a shift toward alternative treatment approaches such as CAZ-AVI.
The findings indicate growing acceptance of rapid diagnostic tools and increased adoption of early treatment approaches among the surveyed intensivists.
Conclusion
The two-phase survey demonstrates the value of structured digital outreach in gathering clinical insights from specialized healthcare professionals.
By combining weekly SMS communication with digital platform engagement, the initiative reached a
